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What’s already known about this topic? 
• A significant rate of sensitisation to oxidised limonene and linalool has been 
demonstrated worldwide  
• Distinguishing true positives from irritant reactions may be difficult 
What does this study add? 
• Higher concentrations of limonene hydroperoxides (0.3%) and linalool 
hydroperoxides (1.0%) detect more sensitised patients 
• Dilutions should be tested in patients with questionable reactions 
What’s new? 
• Limonene hydroperoxides 0.3% and linalool hydroperoxides 1.0% should be 
added to the British baseline patch test series 
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ABSTRACT 
Background: 
There is a significant rate of sensitisation worldwide to the oxidised fragrance 
terpenes limonene and linalool.  Patch testing to oxidised terpenes is not routinely 
carried out; the ideal patch test concentration is unknown.  
Objectives: 
To determine the best test concentrations for limonene and linalool hydroperoxides, 
added to the British baseline patch test series, to optimise detection of true allergy 
and minimise irritant reactions. 
Methods: 
During 2013-2014, 4563 consecutive patients in 12 UK centres were tested to 
hydroperoxides of limonene in petrolatum (pet.) 0.3%, 0.2% and 0.1%, and 
hydroperoxides of linalool 1.0%, 0.5% and 0.25% pet. Irritant (IR) reactions were 
recorded separately from doubtful (?+) reactions. Concomitant reactions to other 
fragrance markers and clinical relevance were documented. 
Results: 
Limonene hydroperoxide 0.3% gave positive reactions in 241 (5.3%) patients, irritant 
reactions in 93 (2.0%) and doubtful reactions in 110 (2.4%). Linalool hydroperoxide 
1.0% gave positive reactions in 352 (7.7%), irritant reactions in 178 (3.9%), and 
doubtful reactions in 132 (2.9%). 119 patients with crescendo reactions to 0.3% 
limonene would have been missed if only tested with 0.1%. 131 patients with 
crescendo reactions to 1.0% linalool would have been missed if only tested with 
0.25%. In almost two-thirds of patients with positive patch tests to limonene and 
linalool the reaction was clinically relevant. The majority of patients did not react to 
any fragrance marker in the baseline series.  
Conclusions: 
We recommend that limonene hydroperoxides be tested at 0.3% and linalool 
hydroperoxides at 1.0% in the British baseline patch test series. 
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Background  
Limonene and linalool are terpene fragrances of natural origin present in the 
majority of detergents and cosmetics purchased by the UK consumer.
1
 While 
uncommon fragrance allergens in their natural state, they become potent allergens 
following air-oxidation.
2
 The newly-formed oxidation products include 
hydroperoxides, largely responsible for sensitisation.  
Limonene, the main constituent of citrus peel oil, has a fresh lemon aroma and is 
found in half of all household detergents and 98% of women’s fragrances.
1,3
 Linalool 
has a flowery smell and is present in a variety of essential oils including lavender, 
jasmine, geranium, ylang-ylang, rosewood and sage. Similarly to limonene, it is found 
in most fine fragrances.
4
 It has been identified as the fragrance terpene to which 
there is the most frequent exposure.
3,5
 
European legislation stipulates that 26 named fragrances, including limonene and 
linalool, must be indicated in the list of ingredients on cosmetic and detergent 
products, if their concentration exceeds 0.001% (10ppm) in leave-on products (e.g. a 
moisturiser) and 0.01% (100ppm) in rinse-off products (e.g. a shampoo). If they are 
added as part of an essential oil, consumers may not be aware of their presence in 
certain products.
6
 Although essential oils containing limonene and linalool should 
have them listed on the label if present at threshold levels of 10ppm in the finished 
product for leave on and 100ppm for rinse off products, aromatherapy products are 
not covered by the Cosmetics Regulations. (Regulation (EC) No. 1223/2009). 
A widely-used household cosmetic brand marketed in the UK labelled ‘no 
artificial perfume or colour’, contains unlabelled limonene and linalool, inherent 
constituents of pelargonium graveolens (geranium) oil.  
Commercial patch test preparations of oxidised limonene and linalool have in 2012 
become available from Chemotechnique Diagnostics (Vellinge, Sweden) 
(Hydroperoxides of limonene 0.3% in petrolatum (pet.) (H-032A) and 
Hydroperoxides of linalool 1.0% pet (H-031A)), but are not routinely tested.  
A recent national UK audit, published in 2014, demonstrated a significant rate of 
allergy to limonene hydroperoxides 0.3% and linalool hydroperoxides 1.0%.
2
 
However, in this audit the numerous doubtful and irritant reactions had not been 
grouped separately for purposes of analysis, nor had data been gathered on 
concomitant reactions to other fragrance markers and on clinical relevance.  
The ideal concentration for patch testing oxidised terpenes would keep doubtful and 
irritant reactions to an acceptable level whilst optimising the chances of detecting a 
true contact allergy, and minimising the risk of active sensitisation. Hence, a further 
audit, intended to determine the optimal concentration of terpene hydroperoxides 
for patch testing, was set up. The intentions were: 1.To specifically compare 3 
concentrations of each terpene hydroperoxide; 2.To distinguish irritant from 
doubtful reactions; 3.To assess concomitant reactions to other fragrance markers; 
and 4.To address the issue of clinical relevance.    
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Method 
During a twelve month period between October 2013 and October 2014, data were 
collected from 12 UK and Irish dermatology departments (Bath, Birmingham, Cardiff, 
Cork, Dundee, East Kent, Leeds, Leicester, Newport, Oxford, Sheffield and Swansea).  
4563 consecutive patients (including a small number of children and adolescents) 
were tested to an extended British baseline patch test series including 
hydroperoxides of limonene at concentrations of 0.3%, 0.2% and 0.1% pet. 
(equivalent to oxidised limonene 3.0%, 2.0% and 1.0% respectively), and 
hydroperoxides of linalool 1.0%, 0.5% and 0.25% pet.(equivalent to oxidised linalool 
6.0%, 3.0% and 1.5% respectively), plus other series as clinically indicated.  All 
allergens were produced by Chemotechnique Diagnostics, who confirmed the 
content of hydroperoxides. The batch to batch variation was: limonene 
hydroperoxide 0.3%; 0.27-0.33%, linalool hydroperoxide 1.0%; 0.95-1.05%, limonene 
hydroperoxide 0.2%; 0.18-0.22%, linalool hydroperoxide 0.5%; 0.47-0.53%, limonene 
hydroperoxide 0.1%; 0.09-0.11%, linalool hydroperoxide 0.25%; 0.24-0.26%.    
 
Allergens were stored and dispensed according to manufacturers’ instructions, used 
within the recommended stability periods (8 months for limonene, 12 months for 
linalool), and were laid out immediately prior to application by experienced patch 
test nurses.  8mm Finn Chambers® (Epitest Oy, Tuusula, Finland) on Scanpor® tape 
(Norgesplaster A/S, Vennsela, Norway) were used in 11 centres. One centre 
(Swansea) used IQ Ultimate
TM 
chambers. The amount of allergen applied was 
enough to fill the well of the disk but not extrude when the patch was applied to the 
patient’s back, approximately 20 mg (40 mg/cm2) for Finn chambers and 25 mg (36 
mg/cm2) for IQ chambers. Patches were applied for 48 hours.  
Readings were carried out on Day 2 (D2) and 4 (D4) (or day 5 (D5) in one centre) by a 
dermatologist experienced in interpreting patch tests.  Allergic patch test reactions 
were scored according to the guidelines of the International Contact Dermatitis 
Research Group criteria (Table 1).
7
 Irritant (IR) reactions were characterised as well-
defined erythema at D2 limited to the exposure area with a lack of infiltrate and with 
a decrescendo effect between D2 and D4/5, particularly in patients who had irritant 
reactions to other known irritant patch test preparations, or to the Scanpor tape. 
Sharp-edged margins and a wrinkled test area surface were other features indicative 
of irritant reactions. Doubtful (?+) reactions were defined as homogenous macular 
erythema with minimum to no infiltration, limited to the exposure area, without a 
decrescendo effect, or appearing only at D4.  
Clinical relevance was determined as either relevant or of unknown relevance by the 
clinician doing the final patch test reading. Examples of relevant reactions were 
those in patients with a clear current or previous history of fragrance allergy, or 
dermatitis from a product labeled to contain limonene or linalool, or dermatitis from 
a botanical oil with limonene or linalool as a constituent, or a positive repeated open 
application test to such a product. The frequency of positive reactions to each 
concentration of limonene and linalool hydroperoxide, and the clinical 
characteristics of patients were recorded. These included age, sex, presence of 
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atopic dermatitis and duration of rash. Reactions to the other fragrance markers in 
the baseline series (Fragrance mix (FM)1, FM2, Myroxylon pereirae, Hydroxyisohexyl 
3-cyclohexene carboxaldehyde and colophonium) were recorded.  
We compared associations between age, gender, duration and history of atopic 
dermatitis, and presence of a positive patch test to either limonene 0.3% or linalool 
1.0% on day 4/5. We used Chi square test for categorical variables (gender, history of 
atopy), analysis of variance (ANOVA) for continuous (age) and Kruskal-Wallis for 
continuous non-normal variables (duration of dermatitis). Due to the repeated 
nature of the data collected, we used Bhapkar’s test of marginal homogeneity to 
compare reactions to limonene and linalool at each concentration on the same day 
and between day 2 and day 4. All analyses were undertaken using R version 3.3.2.  
Results 
A total of 4563 patients were patch tested at 12 UK centres (Table 2). 463 (10.1%, 
95% CI 9.3%-11.1%) had positive patch test reactions (1+, 2+, or 3+) to one or both 
terpene hydroperoxides on D4/5: 111 (2.4%, 95% CI 2.0%-2.9%) were positive to 
limonene hydroperoxide 0.3% alone and 222 (4.9%, 95% CI 4.3%-5.5%) to linalool 
hydroperoxide 1.0% alone (Figure 1).  130 of the 463 (2.8%, 95% CI 2.4%-3.4% of the 
4563 tested) had a positive reaction (1+, 2+ or 3+) to both limonene and linalool. 
Hence the total number positive to limonene 0.3% was 241 (5.3%, 95% CI 4.7%-6.0%) 
and the total positive to linalool 1.0% was 352 (7.7%, 95% CI 7.0%-8.5%). 93 (2.0%, 
95% CI 1.7%-2.5%) irritant reactions to limonene hydroperoxide 0.3% were recorded 
and 178 (3.9%, 95% CI 3.4%-4.5%) to linalool hydroperoxide 1.0% (Table 2).  110 
(2.4%, 95% CI 2.0%-2.9%) had doubtful reactions to limonene hydroperoxide 0.3% 
and 132 (2.9%, 95% CI 2.4%-3.4%) had doubtful reactions to linalool hydroperoxide 
1.0%.  
The results from the 5 largest centres testing more than 500 patients per year, all of 
whom used 8mm Finn chambers and a standardised dose, are almost identical to our 
overall results; 163/3091 (5.3%) of patients were positive to limonene 
hydroperoxides 0.3% and 245/3091 (7.9%) to linalool hydroperoxides 1.0%.  
The mean (+ SD) age of the 241 patients with 1+ to 3+ positive reactions to limonene 
hydroperoxide 0.3% was 41.3 years (SD 18.1).  There were 166 females (81.0%).  The 
median duration of dermatitis was 24 months (IQR 12-60). 81 (33.6%) were atopic.  
The mean (+SD) age of the 352 patients with 1-3+ positive reactions to linalool 
hydroperoxide 1.0% was 45.0 years (SD 19.2).  There were 226 females (77.4%).  The 
median duration of dermatitis was 33 months (IQR 12-60). 113 (32.1%) were atopic 
(Table 3).    
Table 4 shows the effect of increasing concentration on the number of negative, 
positive, doubtful and irritant reactions at D2 and D4/5 for limonene and linalool. At 
D4/5, 0.1% limonene had the lowest rate of positive reactions (1.3%), and 1.0% 
linalool the highest rate (7.7%). As the concentration of limonene and linalool 
increased, the rate of both positive and irritant reactions increased (all p-values < 
0.001). 
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Looking for a crescendo effect, indicative of true allergic positive reactions,
8
 we 
compared patch test reactions on day 2 versus day 4 at the different concentrations 
of limonene and linalool. When testing with limonene 0.3% (Tables 5a-5c; Figure 2), 
161 patients had negative patch tests on D2 which became positive on D4, compared 
with 100 at 0.2%, and 42 at 0.1%.  When testing with linalool 1.0% (Tables 5d-5f; 
Figure 3), 194 patients had negative patch tests on D2 which became positive on D4, 
compared with 128 at 0.5%, and 63 at 0.25%. We found more positive reactions on 
day 4 versus day 2 for both limonene and linalool at all concentrations (all P-values < 
0.001).  
Clinical relevance was recorded in 1017 of the 1047 patients who had IR, ?+, or 1+ to 
3+ positive reactions to limonene or linalool. In almost two-thirds of patients with 
positive patch tests to limonene and linalool the reaction was deemed clinically 
relevant. Increasing the concentration of limonene and linalool had no effect on 
clinical relevance (Table 6).  
Concomitant reactions were recorded in 824 of the 1047 patients who had an 
irritant, ?+, or 1+ to 3+ positive reaction to limonene or linalool 
hydroperoxide.  There was no correlation between the concentrations of limonene 
and linalool and the percentage of patients with concomitant positive reactions to 
other fragrance markers. In patients with 2+ and 3+ reactions, reactions to other 
baseline series fragrance markers appeared more frequent than in those with 1+, 
irritant, doubtful or negative reactions, however the numbers of patients were small 
in the 2+/3+ group (statistical analysis was not performed). (Tables 7 and 8; Figures 4 
and 5). Only 229 of the 824 patients (27.8%) reacted to any other fragrance marker 
in the baseline series. 
 
Discussion 
This large multicentre UK audit confirms the high rate of allergy to 0.3% limonene 
hydroperoxides (5.3%) and 1% linalool hydroperoxides (7.7%) in consecutively patch 
tested patients, which we previously reported.
2
 A very similar rate of contact 
sensitization to 0.3% limonene hydroperoxides of 5.1% has recently been reported in 
Spain.
9
 Our results, however, show higher rates of positive patch tests than two 
recent international multicentre studies of consecutive dermatitis patients from 6-9 
test centres, which showed positive reactions to R-limonene hydroperoxides 0.3% in 
2.3% of 2411 patients and oxidised linalool 1.0% in 5.3% of 2900 patients 
respectively.
10,11
  
We found a broadly similar rate of questionable (doubtful and irritant) reactions as 
we had previously. Limonene 0.3% had a rate of irritant reactions of 2.0% and 
doubtful reactions of 2.4% and linalool 1.0% had a rate of irritant reactions of 3.9% 
and doubtful reactions of 2.9%. This gives a combined rate of doubtful and irritant 
reactions to limonene of 4.4% and to linalool of 6.8%, very similar to the overall rate 
of 7.3% in our previous paper, where irritant and doubtful reactions to limonene and 
linalool were grouped together.
2
 In a recent international multicentre study the 
combined rate of irritant and doubtful reactions to 0.3% limonene hydroperoxides 
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was 7.9% (irritant 0.9% and doubtful 7.0%).
11
 In another study, using 1% linalool 
hydroperoxides, the combined rate of irritant and doubtful reactions was 6.7%, 
irritant 0.14-0.3% and
 
doubtful 6.4%).
12 
  
Differences in rates of irritant and doubtful reactions between studies illustrate the 
great difficulty in interpretation of patch test results to these chemicals. These 
differences are also seen within studies, for example Table 2 illustrates the variation 
between centres in our audit in rates of irritant reactions: from 0-6.8% for limonene 
and 0-17% for linalool. Similarly, doubtful reactions ranged from 0-17.3% for 
limonene 0.3% and 0.3-19.2% for linalool 1%. Interpretation of positive patch test 
reactions requires experienced clinical judgement and is a particular challenge with 
oxidized terpenes. It should be acknowledged that in this audit patch tests were read 
on differing days in different centres, with some centres having a D5 reading, which 
could influence the rate of irritant reactions. 
A Repeated Open Application Test (ROAT), is recommended in The European Society 
of Contact Dermatitis guidelines to be carried out in cases of doubtful reactions.
13
 An 
alternative or additional method is to test serial dilutions of the allergen,
13
 as irritant 
reactions may abruptly disappear at lower concentrations whereas allergic reactions 
may show a gradually reducing strength of response with reducing concentration. 
Dilutions of hydroperoxides of limonene and linalool are now commercially available 
from Chemotechnique (0.2% hydroperoxides of limonene (H-032B) and 0.5% 
hydroperoxides of linalool (H-031B). 
Brasch et al. showed that crescendo or plateau reaction patterns at Days 1 to 3 were 
significantly more often observed in relevant allergic reactions.
8
 We used a 
crescendo or plateau pattern to assist in distinguishing positive from doubtful and 
irritant reactions. As the concentration of limonene increased, the greatest 
difference in detection rates of patients with negative patch tests at D2 becoming 
positive at D4/5 (crescendo reactions) was when the concentration of limonene was 
increased from the lowest concentration, 0.1%, to the highest, 0.3%, resulting in an 
extra 119 patients with allergy to limonene being detected who would otherwise 
have been missed. The same was found for the increase in concentration of linalool 
from 0.25% to 1.0%, when 131 extra patients with linalool allergy were detected. 
The highest concentrations, 0.3% limonene and 1.0% linalool hydroperoxide 
respectively, also demonstrated the largest number of cases where a questionable 
reaction at D2 became a definite positive reaction at D4. This supports the need to 
test the highest concentrations for both limonene and linalool, as testing at 0.1% or 
0.2% limonene and 0.25% or 0.5% linalool only would miss these cases.  
The rate of irritant reactions also increased with increasing concentrations.  For 
limonene, the rate of irritant reactions increased from 0.6-2.0% as the concentration 
increased from 0.1-0.3%. For linalool the rate of irritant reactions increased from 
1.1-3.9% as the concentration increased from 0.25-1.0%. It is our opinion that this 
increase in rate of irritant reactions, while undesirable, is counterbalanced by the 
increase in detection of sensitisation cases at higher concentrations.  
Clinical relevance in patients with positive reactions was present in almost two-
thirds of our patients, but there was no correlation between increasing 
Page 8 of 29British Journal of Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 9
concentration of limonene and linalool hydroperoxide and clinical relevance. A 
recent international study found that exposure to products containing limonene was 
assessed as being relevant for the patient’s dermatitis in only 36% of all patients 
with a positive patch test to 0.3% limonene hydroperoxide. However, in the 
subgroup of patients attending Barcelona and Copenhagen, more than 70% were 
deemed as relevant, similar to our results.
12
 
Recent international multicentre studies showed that only approximately 40% of 
patients reacting to oxidized linalool and/or R-limonene had concomitant reactions 
to other markers of fragrance allergy, in keeping with our finding that more than 
two-thirds of patients sensitised to oxidized terpenes do not have this detected by 
fragrance screening markers in the baseline patch test series.
10,11
 These results are 
also supported by the finding of Matura et al. that only 29-33% of patients with 
positive patch tests to oxidized R- or S-limonene also reacted to other fragrance 
markers,
14
 and by other studies.
15-17
 A recent paper showed concomitant reactions 
to another baseline series fragrance marker to occur in 42.1% of patients reacting to 
0.3% limonene hydroperoxides
18
 and 39.5% reacting to 1.0%. linalool 
hydroperoxides, fairly similar to our overall results
18
.  
In our study, there was no clear relationship between the patch test concentration 
of limonene and linalool and reactions to other fragrance markers. We did, however, 
find that patients with 2+ and 3+ reactions appeared more likely to have reactions to 
other fragrance markers than those with 1+ reactions, although the numbers of 
patients with 2+/3+ reactions were small.  This is in keeping with Christensson’s 
finding (testing oxidized linalool 4.0% - 11% pet.) that the strength of the positive 
patch test reaction correlated with the likelihood of a positive patch test to other 
fragrance markers, being 28-43% in patients with 1+ reactions and 75-80% in 
patients with 2-3+ reactions.
19
 The same authors have shown that cross-reactivity of 
hydroperoxide haptens only occurs where the haptens have overall very similar 
structures.
20
 We also found that positivity to other fragrance markers could not be 
used to clearly distinguish allergic from doubtful reactions. Our results clearly 
illustrate that standard screening markers for fragrance allergy in the baseline series 
(such as FM 1 + 2) are not adequate to detect allergy to oxidised terpenes. Patients 
with fragrance allergy will be missed unless oxidised limonene and linalool are 
routinely tested.  
Atopic dermatitis did not appear to be associated with positive (1+ to 3+) versus 
irritant or doubtful reactions to limonene or linalool although one might have 
expected irritant reactions to be more frequent in atopic patients. A previous report 
found no association between atopy and allergy to FM 1.
21
  
It has been demonstrated, through repeated open application testing, that exposure 
to low concentrations of oxidised linalool causes eczema in allergic patients.
22
 This is 
highly relevant for many consumers previously sensitised to oxidised linalool since 
they may be at risk of elicitation of dermatitis with the low concentrations present in 
everyday personal hygiene products. The increasing use of ‘natural ingredient based 
cosmetics’ is a further hazard, as these contain essential oils (which may already 
contain oxidised terpenes when received from a producer,
18
 or can subsequently 
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oxidise during storage
23
). Pesonen et al. reported occupational hand dermatitis due 
to exposure to cosmetic products scented with limonene.
24
 The range in 
occupational groups affected by dermatitis to oxidised limonene is broad; from 
laboratory technicians to masseurs.
12
 
 
Unless oxidised limonene and linalool are used as a screen for fragrance allergy, 
patients with clinically relevant sensitisation will be missed. Therefore, we suggest 
that the baseline British patch test series is extended to include limonene 
hydroperoxides 0.3% (H-032A) and linalool hydroperoxides 1.0% (H-031A). Patients 
with doubtful reactions should have a ROAT with suspected products or have 
dilutions of the hydroperoxides tested (0.2% hydroperoxides of limonene and 0.5% 
hydroperoxides of linalool). 
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Table 1.  Scoring of patch tests according to the International Contact Dermatitis 
Research Group.
7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Score Reaction 
0 Negative 
?+ Doubtful: erythema only 
1+ Weak (non-vesicular) positive allergic reaction; erythema, infiltration 
and possibly papules 
2+ Strong (vesicular) positive allergic reaction; erythema, infiltration, 
papules and vesicles 
3+ Extreme positive allergic reaction; bullous reaction 
IR Irritant reaction 
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  Limonene 0.3% day 4/5 Linalool 1.0% day 4/5 
Site Total tested Irritant ?+ 1+/2+/3+ Irritant ?+ 1+/2+/3+
  N % N % N % N % N % N 
Centres seeing 
500 + 
patients/year 
 
Leeds 758 0 0.0 5 0.7 26 3.4 0 0.0 5 0.7 34 
Oxford 695 13 1.9 0 0.0 46 7.0 13 1.9 5 0.7 43 
Dundee 557 24 4.3 8 1.4 50 9.4 61 11.0 14 2.5 78 
Newport 550 4 0.7 1 0.2 18 3.0 4 0.7 4 0.7 37 
Sheffield 531 36 6.8 33 6.2 23 4.6 64 12.1 43 8.1 53 
Subtotal 3091 77 2.5 47 1.5 163 5.3 142 4.6 71 2.3 245 
Centres seeing 
<500 
patients/year 
 
Leicester 341 6 1.8 2 0.6 9 2.3 8 2.3 1 0.3 12 
Cardiff 281 0 0.0 1 0.4 14 5.0 0 0.0 1 0.4 21 
Birmingham 250 0 0.0 23 9.2 0 0.0 0 0.0 24 9.6 0 
Swansea 191 0 0.0 11 5.8 32 17 0 0.0 8 4.2 32 
Bath 165 10 6.1 3 1.8 4 2.2 28 17.0 1 0.6 10 
East Kent 140 0 0.0 5 3.6 11 7.9 0 0.0 6 4.3 26 
Cork 104 0 0.0 18 17.3 8 8.0 0 0.0 20 19.2 6 
Subtotal 1472 16 1.1 63 4.3 78 5.3 36 2.4 61 4.1 107 
All 4563 93 2.0 110 2.4 241 5.3 178 3.9 132 2.9 352 
Table 2.  Total number of patients patch tested at each centre and the number and 
percentage of irritant, doubtful and positive reactions to hydroperoxides of (a) 
limonene 0.3% and (b) linalool 1.0% at day 4/5. There are subtotals for the five 
centres patch testing larger numbers of patients (500+ per year) as well as a subtotal 
for the remaining seven centres patch testing less than 500 patients per year. 
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 Irritant ?+ 1/2/3+ p value 
Limonene 0.3% D4/5     
N 93 110 241  
Mean age (SD)
1
 52.3 (18.6) 43.3 (18.9) 41.3 (18.1) <0.001 
Female gender        
N (%)
2
 
48 (67.6%) 83 (79.8%) 166 (81.0%) 0.06 
Median duration, 
months (IQR)
3
 
36 (12-90) 24 (12-84) 24 (12-60) 0.45 
Atopic N (%)
2
 33 (35.9%) 29 (33.7%) 81 (33.6%) 0.95 
Linalool 1.0% D4/5     
N 178 132 352  
Mean age (SD)
 1
 50.6 (17.8) 45.5 (19.6) 45.0 (19.2) 0.03 
Female gender        
N (%)
2
 
87 (69.6%) 92 (76.7%) 226 (77.4%) 0.22 
Median duration, 
months (IQR)
3
 
24 (12-60) 24 (12-84) 33 (12-60) 0.55 
Atopic N (%)
2
 62 (35.6%) 36 (34.3%) 113 (32.1%) 0.83 
Table 3. Demographics of 1047 patients with irritant (IR), doubtful (?+) or positive 
patch test (1 to 3+) reactions to limonene 0.3% and linalool 1.0% on Day 4/5. 
Patients with irritant reactions were significantly older than those with 1+ or 2+/3+ 
reactions, for both limonene and linalool.
1
p values from ANOVA, 
2
p values from Chi 
square test, 
3
p values from Kruskal-Wallis test. 
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(a) 
 0.1% Limonene 0.2% Limonene 0.3% Limonene 
  Day 2 Day 4/5 Day 2 Day 4/5 Day 2 Day 4/5
 N % N % N % N % N % N %
Negative 4517 99.0 4424 97.0 4449 97.5 4278 93.8 4364 95.6 4119 90.3
Irritant 8 0.2 28 0.6 31 0.7 40 0.9 66 1.4 93 2.0
?+ 27 0.6 53 1.2 50 1.1 98 2.1 84 1.8 110 2.4
1+/2+/3+ 11 0.2 58 1.3 33 0.7 147 3.2 49 1.1 241 5.3
 
(b) 
 0.25% Linalool 0.5% Linalool 1.0% Linalool 
  Day 2 Day 4/5 Day 2 Day 4/5 Day 2 Day 4/5
 N % N % N % N % N % N 
Negative 4419 96.8 4264 93.4 4290 94.0 4086 89.5 4123 90.4 3901 85.5
Irritant 36 0.8 51 1.1 80 1.8 89 2.0 184 4.0 178 
?+ 72 1.6 133 2.9 121 2.7 157 3.4 173 3.8 132 
1+/2+/3+ 36 0.8 115 2.5 72 1.6 231 5.1 83 1.8 352 
Table 4. Effect of increasing concentration on th  number of negative, irritant, 
doubtful and positive reactions on day 2 and day 4/5 for (a) limonene and (b) linalool. 
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 0.1% Limonene, Day 4  
  
0.1% Limonene, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4411 
97.7% 
  
25 
0.6% 
  
39 
0.9% 
  
37 
0.8% 
  
5 
0.1% 
  
4517 
 
Irritant 
N 
Row(%) 
  
0 
0.0% 
  
3 
37.5% 
  
2 
25.0% 
  
3 
37.5% 
  
0 
0.0% 
  
8 
 
?+ 
N 
Row(%) 
  
9 
33.3% 
  
0 
0.0% 
  
11 
40.7% 
  
6 
22.2% 
  
1 
3.7% 
  
27 
 
1+ 
N 
Row(%) 
  
4 
36.4% 
  
0 
0.0% 
  
1 
9.1% 
  
5 
45.5% 
  
1 
9.1% 
  
11 
 
2+/3+ 
N 
Row(%) 
  
0 
0% 
  
0 
0% 
  
0 
0% 
  
0 
0% 
  
0 
0% 
  
0 
 
Total 4424 28 53 51 7 4563 
Table 5a. 0.1% limonene: Day 2 versus Day 4. 
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 0.2% Limonene, Day 4  
  
0.2% Limonene, Day 2 Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4239 
95.3% 
  
28 
0.6% 
  
82 
1.8% 
  
97 
2.2% 
  
3 
0.0% 
  
4449 
 
Irritant 
N 
Row(%) 
  
14 
45.2% 
  
11 
35.5% 
  
2 
6.5% 
  
4 
12.9% 
  
0 
0.0% 
  
31 
 
?+ 
N 
Row(%) 
  
20 
40.0% 
  
1 
2.0% 
  
12 
24.0% 
  
16 
32.0% 
  
1 
2.0% 
  
50 
 
1+ 
N 
Row(%) 
  
5 
15.6% 
  
0 
0.0% 
  
2 
6.2% 
  
21 
65.6% 
  
4 
12.5% 
  
32 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
1 
100.0% 
  
1 
 
Total 4278 40 98 138 9 4563 
Table 5b. 0.2% limonene: Day 2 versus Day 4. 
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 0.3% Limonene, Day 4  
  
0.3% Limonene, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4062 
93.1% 
  
66 
1.5% 
  
75 
5.5% 
  
157 
3.6% 
  
4 
0.1% 
  
4364 
 
Irritant 
N 
Row(%) 
  
31 
47.0% 
  
24 
36.4% 
  
3 
4.5% 
  
8 
12.1% 
  
0 
0.0% 
  
66 
 
?+ 
N 
Row(%) 
  
21 
25.0% 
  
2 
2.4% 
  
27 
32.1% 
  
32 
38.1% 
  
2 
2.4% 
  
84 
 
1+ 
N 
Row(%) 
  
5 
11.4% 
  
1 
2.3% 
  
5 
11.4% 
  
29 
65.9% 
  
4 
9.1% 
  
44 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
5 
100.0% 
  
5 
 
Total 4119 93 110 226 15 4563 
Table 5c. 0.3% limonene: Day 2 versus Day 4. 
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 0.25% Linalool, Day 4  
  
0.25% Linalool, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4228 
95.7% 
  
33 
0.7% 
  
95 
2.1% 
  
61 
1.4% 
  
2 
0.0% 
  
4419 
 
Irritant 
N 
Row(%) 
  
11 
30.6% 
  
15 
41.7% 
  
4 
11.1% 
  
6 
16.7% 
  
0 
0.0% 
  
36 
 
?+ 
N 
Row(%) 
  
21 
29.2% 
  
2 
2.8% 
  
32 
44.4% 
  
16 
22.2% 
  
1 
1.4% 
  
72 
 
1+ 
N 
Row(%) 
  
4 
11.8% 
  
1 
2.9% 
  
2 
5.9% 
  
26 
76.5% 
  
1 
2.9% 
  
34 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
1 
50.0% 
  
1 
50.0% 
  
2 
 
Total 4264 51 133 110 5 4563 
Table 5d. 0.25% linalool: Day 2 versus Day 4. 
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 0.5% Linalool, Day 4  
  
0.5% Linalool, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4007 
93.4% 
  
55 
0.3% 
  
100 
2.3% 
  
121 
2.8% 
  
7 
0.2% 
  
4290 
 
Irritant 
N 
Row(%) 
  
40 
50.0% 
  
25 
31.2% 
  
8 
10.0% 
  
7 
8.8% 
  
0 
0.0% 
  
80 
 
?+ 
N 
Row(%) 
  
33 
27.3% 
  
6 
5.0% 
  
40 
33.1% 
  
41 
33.9% 
  
1 
0.8% 
  
121 
 
1+ 
N 
Row(%) 
  
6 
9.4% 
  
3 
4.7% 
  
8 
12.5% 
  
45 
70.3% 
  
2 
3.1% 
  
64 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
1 
12.5% 
  
4 
50.0% 
  
3 
37.5% 
  
8 
 
Total 4086 89 157 218 13 4563 
Table 5e. 0.5% linalool: Day 2 versus Day 4. 
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 1.0% Linalool, Day 4  
  
1.0% Linalool, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
3761 
91.2% 
  
97 
2.4% 
  
71 
1.7% 
  
177 
4.3% 
  
17 
0.4% 
  
4123 
 
Irritant 
N 
Row(%) 
  
96 
52.2% 
  
63 
34.2% 
  
10 
5.4% 
  
15 
8.2% 
  
0 
0.0% 
  
184 
 
?+ 
N 
Row(%) 
  
41 
23.7% 
  
14 
8.1% 
  
48 
27.7% 
  
65 
37.6% 
  
5 
2.9% 
  
173 
 
1+ 
N 
Row(%) 
  
3 
4.0% 
  
3 
4.0% 
  
3 
4.0% 
  
56 
74.7% 
  
10 
13.3% 
  
75 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
1 
12.5% 
  
0 
0.0% 
  
3 
37.5% 
  
4 
50.0% 
  
8 
 
Total 3901 178 132 316 36 4563 
Table 5f. 1.0% linalool: Day 2 versus Day 4. 
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 Unknown 
relevance 
Clinically 
relevant 
Total positive           
(1+, 2+, 3+) 
0.1% limonene 19 (33.3%) 38 (66.7%) 57 
0.2% limonene 51 (35.4%) 93 (64.6%) 144 
0.3% limonene 78 (33.5%) 155 (66.5%) 233 
0.25% linalool 47 (41.2%) 67 (58.8%) 114 
0.5% linalool 76 (33.2%) 153 (66.8%) 229 
1.0 % linalool  124 (36.4%) 217 (63.6%) 341 
Table 6. Effect of increasing concentration on clinical relevance for limonene and 
linalool. Relevance data were recorded in 1017 of the 1047 patients who had 
irritant, ?+, 1+, or 2+/3+ reactions to hydroperoxides of limonene or linalool. 
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 Positivity to other fragrance markers 
Limonene, Day 4 0.1% 0.2% 0.3% 
Negative 
N 
Row(%) 
  
191 
26.9% 
  
156 
26.9% 
  
102 
22.3% 
Irritant 
N 
Row(%) 
  
4 
20.0% 
  
6 
16.2% 
  
18 
29.0% 
?+ 
N 
Row(%) 
  
15 
31.9% 
  
20 
25.6% 
  
34 
38.2% 
1+ 
N 
Row(%) 
  
16 
37.2% 
  
43 
35.0% 
  
67 
32.7% 
2+/3+ 
N 
Row(%) 
  
3 
75.0% 
  
4 
66.7% 
  
8 
80.0% 
Table 7. Day 4 Limonene 0.1%, 0.2%, 0.3%: Proportion of people with positivity to other 
fragrance markers (recorded in 824 of the 1047 patients; 229 (27.8%) of these had a positive 
reaction to another fragrance marker). 
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 Positivity to other fragrance markers 
 Linalool, Day 4 0.25% 0.5% 1.0% 
Negative 
N 
Row(%) 
  
132 
23.0% 
  
96 
22.5% 
  
60 
19.9% 
Irritant 
N 
Row(%) 
  
8 
18.6% 
  
10 
13.5% 
  
21 
17.4% 
?+ 
N 
Row(%) 
  
42 
38.2% 
  
39 
29.5% 
  
35 
32.1% 
1+ 
N 
Row(%) 
  
45 
47.9% 
  
80 
43.2% 
  
100 
36.6% 
2+/3+ 
N 
Row(%) 
  
2 
66.7% 
  
4 
66.7% 
  
13 
65.0% 
Table 8. Day 4 linalool 0.25%, 0.5%, 1.0%: proportion of people with positivity to other 
fragrance markers (recorded in 824 of the 1047 patients; 229 (27.8%) of these had a positive 
reaction to another fragrance marker). 
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Figure 1. Concomitant  positive patch test reactions between oxidised limonene 
0.3% and oxidised linalool 1.0%. A total of 463 (10.1%) had positive patch test 
reactions (1+, 2+, or 3+) to one or both terpene hydroperoxides on D4/5: 111 (2.4%) 
were positive to limonene hydroperoxide 0.3% alone and 222 (4.9%) to linalool 
hydroperoxide 1.0% alone.  130 of the 463 had a positive reaction (1+, 2+ or 3+) to 
both limonene and linalool.   
 
 
Page 25 of 29 British Journal of Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 26
 
Figure 2. Change in patch test results from negative to positive between Day 2 and 
Day 4/5 at different concentrations of limonene. 
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Figure 3. Change in patch test results from negative to positive between Day 2 and 
Day 4/5 at different concentrations of linalool. 
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Figure 4. Patch test concentration of limonene and concomitant reactions to other 
fragrance markers (n=824). 
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Figure 5. Patch test concentration of linalool and concomitant reactions to other 
fragrance markers (n=824).  
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